DiaMedica Therapeutics (DMAC) Non Operating Income: 2017-2024

Historic Non Operating Income for DiaMedica Therapeutics (DMAC) over the last 8 years, with Dec 2024 value amounting to $2.3 million.

  • DiaMedica Therapeutics' Non Operating Income rose 81.37% to $292,000 in Q4 2019 from the same period last year, while for Dec 2019 it was $59,000, marking a year-over-year decrease of 94.67%. This contributed to the annual value of $2.3 million for FY2024, which is 17.52% up from last year.
  • Per DiaMedica Therapeutics' latest filing, its Non Operating Income stood at $2.3 million for FY2024, which was up 17.52% from $1.9 million recorded in FY2023.
  • DiaMedica Therapeutics' Non Operating Income's 5-year high stood at $2.3 million during FY2024, with a 5-year trough of $82,000 in FY2021.
  • Moreover, its 3-year median value for Non Operating Income was $1.9 million (2023), whereas its average is $1.5 million.
  • Per our database at Business Quant, DiaMedica Therapeutics' Non Operating Income crashed by 81.11% in 2021 and then skyrocketed by 446.46% in 2023.
  • DiaMedica Therapeutics' Non Operating Income (Yearly) stood at $434,000 in 2020, then plummeted by 81.11% to $82,000 in 2021, then surged by 330.49% to $353,000 in 2022, then skyrocketed by 446.46% to $1.9 million in 2023, then rose by 17.52% to $2.3 million in 2024.